Merck's Earnings Align with Expectations, Stock Declines on 2025 Forecast
Feb 4, 2025
77
Merck's earnings aligned with Wall Street expectations, yet stocks fell due to a lackluster 2025 forecast. The company's reliance on products like Gardasil and Keytruda amid Chinese market challenges is under scrutiny.